PatchSiren cyber security CVE debrief
CVE-2026-83129 Oracle Corporation CVE debrief
A vulnerability in Oracle Sales, a component of Oracle E-Business Suite, allows a low-privileged attacker with network access via HTTP to compromise the product. Successful attacks can result in unauthorized access to critical data or complete access to all Oracle Sales accessible data. The vulnerability affects versions 12.2.3-12.2.15 and has a CVSS 3.1 Base Score of 7.7 (Confidentiality impacts). Defenders should assess exposure and potential impact on Oracle Sales and Oracle E-Business Suite deployments.
- Vendor
- Oracle Corporation
- Product
- Oracle Sales
- CVSS
- HIGH 7.7
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-09-15
- Original CVE updated
- 2026-11-03
- Advisory published
- 2026-09-15
- Advisory updated
- 2026-11-03
Who should care
Defenders responsible for Oracle Sales and Oracle E-Business Suite deployments should assess exposure and potential impact. They should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access due to the vulnerability allowing low-privileged attackers to compromise the product and access critical data. Security teams and vulnerability management teams should also review the vulnerability andits
Why it matters
Defenders should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access due to the vulnerability allowing low-privileged attackers to compromise the product and access critical data.
- Potential unauthorized access to critical data
- Possible complete access to all Oracle Sales accessible data
- Need to verify exposure of affected versions
- Priority on implementing compensating controls
Technical summary
The vulnerability in Oracle Sales, a component of Oracle E-Business Suite, allows a low-privileged attacker with network access via HTTP to compromise the product. Successful attacks can result in unauthorized access to critical data or complete access to all Oracle Sales accessible data. The CVSS 3.1 Base Score is 7.7 (Confidentiality impacts). The vulnerability affects versions 12.2.3-12.2.15 and has a significant impact on confidentiality. Defenders should prioritize verifying exposure of affected versions and assessing the impact of potential data access.
Defensive priority
Defenders should prioritize verifying exposure of Oracle Sales versions 12.2.3-12.2.15 and assessing the impact of potential data access.
Recommended defensive actions
- Verify exposure of Oracle Sales versions 12.2.3-12.2.15
- Assess potential data access impact
- Implement compensating controls to limit data access
- Review vendor guidance for Oracle Sales and Oracle E-Business Suite
- Conduct vulnerability scanning for affected versions
- Monitor for suspicious activity related to Oracle Sales
- Track remediation progress and verify fixes
Evidence notes
The CVE record and NVD detail page provide information on the vulnerability, its impact, and affected versions. The vulnerability allows low-privileged attackers with network access via HTTP to compromise Oracle Sales and access critical data. Defenders should verify exposure of affected versions and assess potential data access impact. The information provided is based on the CVE record and NVD detail page, which offer details on the vulnerability and its severity.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-83129 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-83129
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-83129 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-83129
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://www.oracle.com/security-alerts/cspusep2026.html
[email protected] - Vendor Advisory
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.